INTRODUCTION
Genome-wide association studies have identified many genes that are associated with a risk for mental disorders, such as bipolar disorder, schizophrenia and autism spectrum disorder (ASD). [1] [2] [3] [4] [5] [6] [7] The ANK3 gene is among the most consistently replicated and statistically significant bipolar risk gene identified in these studies. [6] [7] [8] A number of single-nucleotide polymorphisms in ANK3 have been associated with bipolar disorder, and several of these variants have been associated with altered white matter integrity and changes in cortical-striatal-thalamic circuits, as well as with poorer performance on tasks of sustained attention. 9, 10 A 2012 study described decreased levels of ANK3 mRNA expression in schizophrenia patients. 11 Moreover, whole-exome and -genome sequencing studies identified putative causative mutations in coding and noncoding regions of ANK3 in patients with ASD and intellectual disabilities. [12] [13] [14] However, it remains unknown how alterations in ANK3 may contribute to the pathology of mental illness.
ANK3 encodes a scaffolding protein, ankyrin-G, which, in mature neurons, localizes to the axon initial segment and the nodes of Ranvier. 15, 16 Ankyrin-G is required for the assembly and maintenance of the axon initial segment, which is established through its interaction with scaffolding and transmembrane proteins, and voltage-dependent sodium and potassium channels. 16, 17 Recently, several studies have suggested that ankyrin-G is required for establishing and maintaining neuronal polarity, suggesting a central role for this protein in establishing intact neural circuitry. 17, 18 Additionally, ankyrin-G has been shown to be a binding partner of E-cadherin in epithelial cells, and is required, along with β2-spectrin, for the localization of E-cadherin to cell adhesion sites, where it assembles a complex that includes the important Wnt pathway component β-catenin. 19 Canonical Wnt signaling has an important role in neural progenitor proliferation in the developing central nervous system, and is also involved in dendrite development, synaptogenesis and the establishment of axons. [20] [21] [22] [23] Recent studies using comparative genome sequencing of human patients, as well as the examination of neuronal development in rodents, have demonstrated the importance of canonical Wnt signaling in neuropsychiatric disorders, such as schizophrenia, bipolar disorder and ASD. 24, 25 For instance, the product of the gene disrupted in schizophrenia 1 has been shown to regulate several aspects of cortical development such as neural progenitor proliferation and dendritogenesis. [26] [27] [28] [29] Additionally, the autosomal recessive primary microcephaly risk gene ASPM was shown to regulate Wnt signaling and progenitor proliferation during cortical development. 30 These studies highlight the importance of the molecular pathways that underlie early cortical development to the etiology of complex psychiatric and neurodevelopmental disorders.
β-catenin is one of the key components of the Wnt signaling pathway. Upon activation of canonical Wnt signaling, via the interaction of the Wnt peptide with its membrane receptors LDLreceptor-related protein and Frizzled, β-catenin is stabilized in the cytoplasm through the inhibition of glycogen synthase kinase 3 (GSK3β), which normally promotes the proteolytic degradation of β-catenin. Once stabilized, β-catenin then enters the nucleus, where it binds to T-cell factor/lymphoid-enhancing factor (TCF/LEF) family transcription factors to activate the expression of Wnt target genes. 20 In addition to its central role in Wnt signaling, β-catenin also binds to type I cadherins at the cell membrane, linking them to the actin cytoskeleton and thereby having a role in structural organization. 31 Several lines of evidence suggest that altering the levels of β-catenin localized to the catenin-cadherin complex can affect the availability of β-catenin for participation in Wnt signaling. [31] [32] [33] [34] This includes the observation that the sequestration of β-catenin at the cell membrane via overexpression of the cytoplasmic domain of cadherins and the repression of E-cadherin have opposite effects on Wnt signaling. Importantly, it has previously been shown that overexpression of β-catenin can perturb the development of mammalian cortex. 20 In the current study, we show that ankyrin-G is highly enriched in the ventricular zone (VZ) of the embryonic brain and is required for proper neural progenitor proliferation. Ankyrin-G loss-offunction leads to increased neural progenitor proliferation and increased canonical Wnt signaling. This is accompanied by a disruption of the β-catenin/cadherin interaction and increase in the nuclear pool of β-catenin. These results suggest that ankyrin-G can regulate canonical Wnt signaling via the fine-tuning of available levels of β-catenin, thereby ensuring proper brain development. As the importance of canonical Wnt signaling in neuropsychiatric disorders has become increasingly evident, our results shed light on the molecular events that, when influenced by human disease genes, may contribute to the etiology of neuropsychiatric disorders.
MATERIALS AND METHODS

DNA constructs
Short hairpin RNA (shRNA) constructs used in this study were cloned into pLKO.2 PU6-shRNA/PUbiC-eGFP vector available from Broad Institute (Cambridge, MA, USA). Control non-targeting shRNA (Sigma-Aldrich, St Louis, MO, USA; SHC002) and shRNA2 targeting Ank3 were obtained from the Petryshen lab at Massachusetts General Hospital (Boston, MA, USA). shRNA1 targeting Ank3 is obtained from Broad Institute. The sequences can be found in Supplementary Table S1 . Full-length HA-GSK3β (a kind gift from Dr Yingwei Mao at Penn State University, State College, PA, USA) were previously used in Mao et al. 26 Super8XTOPFLASH, a gift from Dr R Moon (University of Washington, Seattle, WA, USA) and a Renilla-Luc-TK reporter (pRL-TK; Promega, Madison, WI, USA) were used for testing TCF transcriptional activity. pCAGIG-Venus was provided by Dr Zhigang Xie (Boston University, Boston, MA, USA).
Animals
Swiss Webster pregnant female mice were purchased from Taconic (Hudson, NY, USA) for in utero electroporation. Ank3 +/ − mice were kind gifts from Bennett Lab (Duke University, Durham, NC, USA) and have been described elsewhere. 35, 36 Cell culture P19 embryonic carcinoma cell line was cultured in Dulbecco's modified Eagle's medium GlutaMAX (10566-016; Invitrogen, Life Technologies, Grand Island, NY, USA) containing 10% fetal bovine serum and penicillin/ streptomycin.
Antibodies and reagents
The following primary antibodies were used in this study: rabbit antiankyrin-G antibody (H-215; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-β-catenin antibody (H-102; Santa Cruz Biotechnology), mouse anti-β-catenin antibody (610153; BD Transduction Laboratories, San Jose, CA, USA), mouse anti-ZO-1 antibody (33-9100; Invitrogen), chicken antigreen fluorescent protein (GFP) antibody (GFP-1020; Aves Labs, Tigard, OR, USA), mouse anti-5-bromo-2'-deoxyuridine (BrdU) antibody (M0744; Clone Bu20a; DakoCytomation, Glostrup, Denmark), rabbit anti-Ki67 antibody (Clone SP6; Lab Vision/Thermo Scientific, Waltham, MA, USA), rabbit antiphospho-histone H3 (Ser10) antibody (06-570; Millipore, Billerica, MA, USA), mouse anti-GSK3β antibody (610202; BD Transduction), mouse anti-pY216 GSK3β antibody (ab75745; Abcam, Cambridge, MA, USA), anti-actin (Sigma-Aldrich; A5316; clone AC-74) and mouse anti-E-cadherin antibody (610181; BD Transduction). Alexa-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) were used for immunohistochemistry and immunocytochemistry. Recombinant human Wnt3a was purchased from R&D Systems (catalog number: 5036-WN, Minneapolis, MN, USA). BrdU was purchased from Sigma-Aldrich (B5002-5G).
Immunohistochemistry
Brain sections. Embryonic cortical brains were drop-fixed overnight in 4% formaldehyde and then transferred to 30% sucrose/phosphate-buffered saline (PBS) solution at 4°C. Brains were embedded in OCT compound (Electron Microscopy Sciences, Hatfield, PA, USA) and sliced into 14-20 μm sections using cryostat. Cryosections were rehydrated with 1 × PBS and blocked for 1-2 h with blocking solution (1 × PBS+10% donkey normal serum+0.3% Triton-X). Following blocking, the cryosections were incubated with primary antibodies overnight at 4°C. Incubation with secondary antibodies were performed for 1 h at room temperature. Finally, cryosections were mounted using ProLong Gold Antifade Reagent (Invitrogen). 
Western blot analysis
Transfected cells were lysed and run on 8% sodium dodecylsulfatepolyacrylamide gels at 60-120 constant voltage to separate, and transferred onto Immobilon-P PVDF membranes (Millipore) at a constant current. Membranes were blocked using 5% bovine serum albumin prepared in TBS-T (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% Tween-20) for 30 min at room temperature. Membranes were incubated with the primary antibodies overnight at 4°C. Next, they were washed three times with TBS-T, followed by incubation with horseradish peroxidase-conjugated secondary antibodies (GE Healthcare, Pittsburgh, PA, USA) for 1 h at room temperature. Following washing with TBS-T, immunoreactivity signals were detected by enhanced chemiluminescence (Perkin-Elmer, Waltham, MA, USA). qPCR Total RNA was collected using the RNeasy Plus Kit (Qiagen, Valencia, CA, USA) 48 h after transfection. Reverse transcription of the mRNA transcripts to produce cDNA for quantitative polymerase chain reaction (qPCR) was achieved using the SuperScript III Reverse Transcriptase (Invitrogen). qPCR was performed using SsoFast Evagreen Supermix (Bio-Rad, Hercules, CA, USA) on CFX96 Real-Time PCR Detection System (Bio-Rad). The reactions were run in triplicates and average of these triplicates were used for statistical analysis. β-Actin was used as internal control. Primer sequences used for qPCR can be found in Supplementary Table 1.
Immunoprecipitation
At 48 h after transfection, transfected cells were lysed in 1 × lysis buffer (150 mM NaCl, 0.1% NP-40, 50 mM Tris (pH 7.5), 5 mM EDTA) with protease inhibitors. Whole-tissue lysates of Ank3 +/ − mice brains were prepared by homogenization in 500 μl solution, including 50 mM Tris, 120 mM NaCl and 0.5% NP-40 with protease inhibitors. Protein (0.5 mg) from each condition was added to protein A sepharose beads (GE Healthcare) conjugated with β-catenin antibody, and incubated overnight at 4°C. The beads were then washed with RIPA and lysis buffers before boiling in Laemmli sample buffer. Following sodium dodecylsulfate-polyacrylamide gel electrophoresis to separate the proteins, blots were probed with E-cadherin antibody.
In utero electroporation
The Institutional Animal Care and Use Committee of Massachusetts Institute of Technology approved all experiments. In utero electroporation was performed as described elsewhere. 37 Briefly, pregnant Swiss Webster mice were anesthetized by intraperitoneal injections of ketamine 1%/xylazine 2 mg ml − 1 , the uterine horns were exposed, and the plasmids mixed with Fast Green (Sigma-Aldrich) were microinjected into the lateral ventricles of embryos. Five pulses of current (50 ms on/950 ms off) were delivered across the head of the embryos. The following voltages were used for different ages: 28-30 V for E13 and 32-35 V for E15. In the DNA mixture, the shRNA plasmid concentration was two-to threefold higher than that of pCAGIG-Venus. For rescue experiments with GSK3β, the ratio between the ankyrin-G shRNA and GSK3β was 3:1 in coexpression DNA mixture.
Luciferase assay
Luciferase assays were performed as described elsewhere. 26 P19 cells at 1 × 10 5 cell per well density were plated into 24-well plates without antibiotics. Cells were transfected with 0.8 μg of shRNA plasmid along with 50 ng of Super8XTOPFLASH and 10 ng of pRL-TK. The media were replaced with one containing antibiotics 2 h after transfection. Either 24 or 36 h after transfection, cells were stimulated with recombinant human Wnt3a for either 16 or 12 h, respectively, in Wnt-stimulated condition. TCF/LEF reporter activity was measured using the Dual-Luciferase Reporter Assay System (Promega). For the rescue experiments, 0.2 μg of HA-GSK3β was co-transfected with 0.6 μg of ankyrin-G shRNA. Firefly luciferase activity was normalized to Renilla luciferase activity in all conditions.
RESULTS
Ankyrin-G is necessary for proper embryonic neural progenitor proliferation
To understand whether ankyrin-G has a role in embryonic cerebral cortical development, we first examined the expression pattern of ankyrin-G in the mouse embryonic day 15 (E15) brain, at which period the proliferation and differentiation of cortical neurons are both at high levels. 38 We found that ankyrin-G is highly expressed in the ventricular surface of developing cortex ( Figure 1a) . Previous studies have shown that endfeet of radial glial cells at the ventricular surface contact neighboring cells through cell junctions, which is composed of two distinct domains: ZO1/mammalian Par3 (mPar3) (apical) and β-catenin/N-cadherin (basal). 39 A more careful examination of ankyrin-G expression at the ventricular surface revealed that ankyrin-G is expressed in both the domains colocalizing with both β-catenin ( Figure 1a , top row of images) and ZO1 ( Figure 1a , bottom row of images). β-Catenin is well known to regulate multiple steps of neurogenesis, including proliferation, differentiation and radial migration. 21, 31 The similarity in the expression patterns of β-catenin and ankyrin-G encouraged us to ask whether ankyrin-G regulates neural progenitor proliferation at early stages of corticogenesis. To address this question, we selected two small hairpin RNAs (shRNA1 and shRNA2) based on their ability to downregulate endogenous ankyrin-G in the P19 embryonic carcinoma cell line, as assayed by western blot and qPCR (Supplementary Figures S1 a and b). We used these two shRNAs to examine the effect of ankyrin-G knockdown on embryonic neural proliferation. We performed in utero electroporation at E13, using a combination of either a non-targeting scrambled shRNA (Control) or ankyrin-G shRNA expression constructs, in addition to a GFP expression construct to label electroporated cells. This was followed by pulse labeling either at E15 or E16 with BrdU, which incorporates into the newly synthesized DNA of replicating cells during the S phase of the cell cycle. The brains were harvested either 2 or 24 h following the BrdU injection and immunolabeled with antibodies against BrdU, the proliferative marker Ki67 (which is only absent from cells in G 0 phase 30 ), and GFP. We found that ankyrin-G knockdown resulted in a significant increase in BrdU incorporation in the GFP-positive (GFP + ) cell population compared with controls after both 2 h (Figures 1b and c To further demonstrate that ankyrin-G is important for neural progenitor proliferation, a complementary experiment was conducted using embryonic Ank3 +/ − mice in which the brain-specific isoform of the ankyrin-G is deleted.
A previously published study demonstrated that Ank3 +/ − mice exhibit bipolar disorder-like behavioral alterations such as reduced anxiety and increased motivation for reward. 35 E15 Ank3 +/ − brains were pulse-labeled with BrdU, harvested and immunolabeled with antibodies against BrdU and Ki67. Images covering the same area were taken from five to seven consecutive brain slices per animal. Consistent with our in utero electroporation assay, we observed a significant increase in the number of BrdU-positive cells in Ank3 +/ − mice compared with wild-type littermates (Figures 1e and f) . The increase in BrdU-labeled cells was accompanied by a significant decrease in cell-cycle exit ( Figures  1e and g ). These results further confirm that ankyrin-G is a positive regulator of neural progenitor proliferation.
Consistent with the observation of increased proliferation, we also observed a significant increase in mitotic activity in the in utero transfected GFP + population in ankyrin-G knockdown animals based on immunoreactivity for phosphohistone H3, 30 which labels mitotic cells (Figures 1h and i) . In addition, we observed a reduced percentage of GFP + cells in the cortical plate (CP) following ankyrin-G knockdown compared with controls ( Figure 1j ). Reduction in GFP + cells in the CP could be due to either a delay in neuronal differentiation or an early neuronal migration defect. To rule out the latter possibility, we analyzed the distribution of GFP + cells exclusively in the intermediate zone/CP Figure 1 for ankyrin-G quantification) (n ⩾ 3, in all cases). (d) Ankyrin-G knockdown reduces interaction between E-cadherin and β-catenin in P19 cells. Immunoprecipitation (IP) with β-catenin antibody followed by immunoblotting (IB) E-cadherin antibody. Input, 5% of the total protein used for immunoprecipitation. (e) Fold change of E-cadherin levels normalized to loading immunoprecipitated β-catenin (Control and shRNA2, n = 5; shRNA1, n = 3). (f) Ankyrin-G knockdown reduces interaction between E-cadherin and β-catenin in E14 Ank3 +/ − mice brain lysates. IP with β-catenin antibody followed by IB E-cadherin antibody. Input, 5% of the total protein used for immunoprecipitation. (g) Fold change of E-cadherin levels normalized to immunoprecipitated β-catenin (WT, n = 7; Ank3 +/ − , n = 6). All analyses, one-way analysis of variance (one-way ANOVA) followed by Dunnett's multiple comparison test, except for (a) where Tukey's multiple comparison test is used, and (g) where unpaired t-test is used; *Po0.05; **Po0.01; ***Po0.001. (f) Loss of ankyrin-G also results in increased nuclear β-catenin levels in proliferating neuroprogenitors in vivo. E15 brain slices from wild-type (top panels) and Ank3 +/ − animals are stained for Ki67 (red), β-catenin (green) and DAPI (blue). (g) Quantification of nuclear β-catenin levels showing increased levels in Ank3 +/ − animals compared with wild-type littermates (WT, n = 16; Ank3 +/ − , n = 22; two different animals per condition). All analyses, one-way analysis of variance (one-way ANOVA) followed by Dunnett's multiple comparison test, except for (i) where unpaired t-test is used; *P o0.05; **P o0.01; ***P o0.001. Scale bar: 10 μm.
the cortex, which are mostly localized to the CP and intermediate zone (Figures 1k and l) . Overall, these results suggest that ankyrin-G knockdown increases progenitor proliferation through reducing cell-cycle exit and neuronal differentiation in the developing brain. 
Ankyrin-G regulates Wnt reporter activity
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Mean Gray Value Regulation of Wnt signaling by ankyrin-G O Durak et al ration, led us to ask whether ankyrin-G has a role in canonical Wnt signaling, of which β-catenin is a core component. Additionally, the Wnt pathway has recently been implicated in several psychiatric disorders via its regulatory function in cortical neurogenesis. 26, 30 To measure Wnt-mediated transcriptional activity, we used a luciferase reporter construct containing seven copies of the TCF/ LEF-binding site (8XSuperTOPFLASH), which can be activated by β-catenin downstream of canonical Wnt signaling. 40, 41 Murine P19 cells were transfected with either control or ankyrin-G-targeting shRNA constructs together with the luciferase reporter construct. We found that, following knockdown of ankyrin-G, TCF/LEF reporter activity was increased in the absence of Wnt3a stimulation compared with controls (Figure 2a, left) . Wnt3a treatment increased the TCF/LEF reporter activity by~2-fold, and AnkG knockdown further upregulated the luciferase activity by~1.5-fold (Figure 2a, right) . These results suggest that ankyrin-G negatively regulates the canonical Wnt signaling pathway. To further decipher this mechanism, we examined the protein expression levels of several canonical Wnt pathway components following ankyrin-G knockdown in P19 cells. We observed that neither the protein (Figures 2b and c) nor the mRNA (Supplementary Figure  S1c) levels of β-catenin were altered following ankyrin-G knockdown compared with control conditions in P19 cells. Moreover, we did not detect differences in GSK3β or phospho-GSK3β (pY216 GSK3β) abundance at the whole-cell level following ankyrin-G knockdown (Figures 2b and c) , suggesting that ankyrin-G does not directly regulate the abundance of these canonical Wnt pathway components.
Ankyrin-G knockdown alters the subcellular localization of β-catenin In addition to its central role in Wnt-mediated TCF/LEF transcription, β-catenin is a core member of a cell-cell adhesion complex comprised of cadherins and catenins (the cadherin-catenin complex). 31 Although it was previously thought that the cadherinbound pool of β-catenin cannot be made available for Wnt signaling, recent studies have suggested instead the existence of an interplay between Wnt signaling and this cell adhesion complex. [31] [32] [33] [34] Specifically, studies show that sequestration of β-catenin at cell-cell adhesion sites via E-/N-cadherin overexpression downregulates Wnt signaling and that the absence of E-cadherin in embryonic stem cells results in the accumulation of free β-catenin in the nucleus. 42 Importantly, ankyrin-G has been identified to be a molecular partner of E-cadherin in epithelial cells and is required for the proper accumulation of E-cadherin to cell-cell contact sites. 19 Therefore, we set out to evaluate how ankyrin-G knockdown affects the integrity of the adherens junctions, as well as to determine changes in the subcellular localization and levels of β-catenin following ankyrin-G knockdown. First, following ankyrin-G knockdown in P19 cells, we examined the association of β-catenin and E-cadherin by immunoprecipitation followed by western blot analysis. We found that the amount of E-cadherin co-immunoprecipitated with β-catenin was markedly decreased in ankyrin-G knockdown conditions compared with controls (Figures 2d and e) . We then repeated this experiment using brain lysates from E14 Ank3 +/ − mice. Consistent with the shRNA-knockdown assay, the interaction between β-catenin and E-cadherin is significantly reduced in Ank3 +/ − mice compared with wild-type littermates (Figures 2f and g ).
We next used immunohistochemistry to determine whether the reduced interaction between E-cadherin and β-catenin might lead to alterations in the subcellular localization of β-catenin. P19 cells were transfected with either nuclear GFP-expressing scrambled shRNA (Control) or ankyrin-G shRNA constructs for 48 h, and then fixed and immunolabeled with antibodies against ankyrin-G and either β-catenin or E-cadherin. In control cells, as observed previously, 19 E-cadherin is localized to the cell membrane, as suggested by the immunoreactivity surrounding the cell. However, ankyrin-G knockdown disrupted the localization of E-cadherin to the cell periphery, resulting instead in a distribution that is more diffuse throughout the cell (Figures 3a and b) . This disrupted E-cadherin phenotype was observed in over 85% of ankyrin-Gknockdown cells, compared with 20% of control cells (Figure 3a) . Consistent with previous observations, β-catenin is mostly localized to the plasma membrane in control shRNA-transfected cells (Figure 3c) . In ankyrin-G-knockdown cells, however, β-catenin localization to the cell periphery was less conspicuous (Figures 3c  and d) .
The β-catenin on the cell membrane is presumably in a complex with E-cadherin. 31 Therefore, since the overall levels of β-catenin do not change in the absence of ankyrin-G (Figures 2b and c and Supplementary Figure S1c) , we hypothesized that reduced levels of E-cadherin/β-catenin at the plasma membrane following ankyrin-G knockdown might increase the levels of free, nonmembrane-bound β-catenin that would then be available for Wnt signaling. We measured nuclear β-catenin levels in transfected cells expressing control shRNA or ankyrin-G shRNAs, as well as nuclear GFP, and observed a marked increase in the amount of β-catenin immunoreactivity localized to the nucleus (Figures 3c-e) . Finally, to confirm that this phenomenon is observed in the brain in vivo, we examined the localization of intracellular β-catenin in cortical progenitor cells in sections from in utero transfected E16 embryos as well as from E15 Ank3 +/ − brains. These sections were immunolabeled with antibodies against β-catenin, Ki67 (to label cycling cells) and 4',6-diamidino-2-phenylindole (DAPI). In both in utero ankyrin-G knockdown and Ank3 +/ − animals, a greater level of β-catenin immunoreactivity was observed throughout the cytoplasm and the nucleus of Ki67 + cells compared with those from control animals (Figures 3f and h, respectively) . Additionally, consistent with the in vitro assay, increased levels of nuclear β-catenin are observed in proliferating cortical neural In ankyrin-G-knockdown condition E-cadherin localized to the plasma membrane is reduced, which in turn results in increased free β-catenin available for Wnt signaling. Upregulation of Wnt signaling results in increased neural progenitor proliferation in the developing cortex. *P o0.05; **P o0.01; ***P o0.001. Scale bar: 100 μm.
progenitor cells (Figures 3f-i) . These data suggest that ankyrin-G knockdown reduces the levels of E-cadherin localized to cadherin--catenin complexes at the plasma membrane, which in turn results in an increased abundance of β-catenin in the nucleus, which is then available for the activation of Wnt signaling.
Increased GSK3β levels ameliorated heightened Wnt signaling caused by ankyrin-G loss-of-function Our findings suggest that ankyrin-G is a negative regulator of the Wnt signaling pathway, as reduced levels of ankyrin-G lead to upregulated TCF/LEF reporter activity and nuclear β-catenin To test this hypothesis directly, we examined the effect of the overexpression of GSK3β, which phosphorylates β-catenin and targets it for ubiquitin-dependent proteasomal degradation, 43, 44 on the ankyrin-G loss-of-function phenotype. In P19 cells, increased TCF/LEF luciferase reporter activity, observed as the result of ankyrin-G shRNA knockdown, was completely reversed by the overexpression of GSK3β (Figure 4a ). These results indicate that ankyrin-G functionally interacts with other Wnt signaling proteins such as GSK3β and that the effects of ankyrin-G knockdown on Wnt signaling activity can be normalized by reducing β-catenin abundance. Taken together, these results further suggest that ankyrin-G is a negative regulator of Wnt signaling.
In vivo defects in neurogenesis caused by ankyrin-G knockdown can be rescued via depletion of β-catenin levels in the developing cortex Given that the ankyrin-G-mediated increase in TCF/LEF activity can be normalized via the expression of a core member (GSK3β) of the Wnt signaling pathway, we hypothesized that the neurogenesis defects caused by in vivo knockdown of ankyrin-G could be rescued via similar manipulations. To examine whether the overexpression of GSK3β can normalize the effects of ankyrin-G knockdown, we performed in utero electroporation at E13 with control or ankyrin-G shRNA and coexpressed either control empty vector or GSK3β overexpression construct. Pulse labeling with BrdU was performed at E16 and brains were harvested 2 h later. As shown earlier, knockdown of ankyrin-G resulted in increased BrdU incorporation in the GFP + cell population, indicating increased proliferation (Figures 4b, c and e) . Consistent with the TCF/LEF luciferase assay, the coexpression of GSK3β with ankyrin-G shRNA led to levels of BrdU incorporation that were indistinguishable from the control condition (Figures 4b, d and e) . Additionally, overexpression of GSK3β was able to rescue the reduced cell-cycle exit phenotype associated with ankyrin-G downregulation (Figures 4b-d  and f) . Finally, we have observed normal GFP + cell distribution upon coexpression of GSK3β with ankyrin-G shRNA (Figure 4g ). These findings demonstrate that the neurogenesis defects resulting from the in vivo knockdown of ankyrin-G can be rescued via dampening Wnt signaling through modulation of other core members of this signaling pathway. These in vivo neurogenesis data, in addition to our in vitro TCF/LEF reporter data, suggest that ankyrin-G exerts its effect on neural progenitor proliferation via controlling the pool of β-catenin participating in Wnt signaling (Figure 4h) .
DISCUSSION
In the current work, we describe a novel role for ankyrin-G in brain development. Extensive work has addressed the role of ankyrin-G as a scaffolding protein required for neuronal polarity and the formation of the axon initial segment. 15, 16 Our findings indicate that ankyrin-G is also an important regulator of neural progenitor cells in the developing cortex. In the current literature, one of the hypotheses posits that early neurodevelopmental changes predispose the individual to the development of schizophrenia in adulthood. 45, 46 Furthermore, ASDs are often associated with increased brain size and malformation of multiple brain regions including the cortex, suggesting alteration in aspects of neurogenesis, such as the proliferation and differentiation of cortical neurons. Our study further supports these findings and also suggests that neurodevelopmental changes likely also underlie bipolar disorder etiology.
Recently, it was shown that ankyrin-G regulates the production of olfactory bulb interneurons in the adult brain via its upregulation in radial glia destined to become SVZ ependymal cells. 47 In this environment, ankyrin-G is required for the SVZ niche assembly through the lateral adhesion of neural progenitors. 47 Consistent with this study, we show that ankyrin-G regulates proliferation and new neuron production in the developing brain via a mechanism that involves E-cadherin localization to the cell membrane and alterations in subcellular β-catenin levels. Our results suggest, for the first time, that ankyrin-G modulates subcellular compartmentalization of β-catenin, and thereby controls the pool of cellular β-catenin available to participate in Wnt signaling in cortical progenitor cells (Figure 4h) .
Our data suggest a model in which ankyrin-G regulates β-catenin anchoring at the progenitor cell membrane via its interaction with E-cadherin. Thus, when ankyrin-G is downregulated, the localization of E-cadherin to the cell membrane is reduced, and β-catenin becomes available to act at the nucleus, where it modulates gene transcription (Figure 4h ). In support of this model, it has previously been shown that ankyrin-G downregulation decreases N-cadherin attachment to the cell membrane in postnatal radial glia progenitors during the SVZ niche formation. 47 Therefore, by regulating the levels of nuclear β-catenin available for Wnt signaling, ankyrin-G acts to regulate negatively progenitor cell proliferation. Accordingly, we were able to counteract the effects of ankyrin-G knockdown upon cortical progenitor proliferation by dampening Wnt signaling via the overexpression of GSK3β, major component of this pathway.
These findings support a hitherto unknown role for ankyrin-G in canonical Wnt signaling. One of the most commonly used medications for the treatment of bipolar disorder, lithium, has been shown to inhibit the function of GSK3β, and this has been suggested to underlie some of lithium's therapeutic effects. 48 This mechanism of lithium action further implicates the canonical Wnt pathway in psychiatric disorders. Although the current study does not have a direct line of evidence suggesting the loss of function of ankyrin-G manifests itself in behavioral changes, a recent study using the same Ank3 +/ − mice line demonstrated that loss of ankyrin-G results in bipolar disorder-like behavioral alterations such as reduced anxiety, which can be considered as higher risk taking, and increased motivation for reward, both of which are features of bipolar disorder. 35 Additionally, they demonstrated that behavioral changes caused by ankyrin-G knockdown can be reversed by lithium administration. 35 However, little is known about the contribution of Wnt signaling to the etiology of mental illnesses.
We showed previously that deficits in neuronal proliferation via modulation of GSK3β/β-catenin signaling underlie neurodevelopmental phenotypes reminiscent of psychiatric disorders, such as schizophrenia. 26 Furthermore, a recent analysis of genome-wide association study data examining pathways implicated in bipolar disorder found that the cadherin and Wnt signaling pathways are enriched in this disease and confirmed ANK3 as a bipolar risk gene. 8 Our study makes the novel observation that ankyrin-G may serve as a common regulator of both cadherin and Wnt signaling pathways by altering the availability of β-catenin. We demonstrate the impact of ankyrin-G loss-of-function on neurogenesis in the embryonic brain, supporting the importance of Wnt signaling in the etiology of neurodevelopmental disorders. These results give new insights into the study of psychiatric disease etiology, and support the idea that alterations in neuronal proliferation are an important element underlying the pathology of mental illness.
Finally, it is worth discussing that ankyrin-G is also highly expressed at the apical domain of radial glial progenitor endfeet at the ventricular surface. mPar3 is exclusively expressed at apical domain during interphase where β-catenin expression is minimal. 39 Additionally, it was shown that mPar3 regulates asymmetric cell division of radial glial progenitors via Notch signaling in the developing neocortex. Therefore, we cannot rule out the possibility that ankyrin-G may also interact with mPar3 in radial glial progenitors, and through which it regulates neural progenitor proliferation. This regulation would be expected to be a β-cateninindependent pathway. Future studies will be needed to address whether ankyrin-G also interacts with mPar3 in neural progenitors in the developing neocortex. 
